These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7506676)
1. Conserved HisVI-17 of the NK-1 receptor is involved in binding of non-peptide antagonists but not substance P. Zoffmann S; Gether U; Schwartz TW FEBS Lett; 1993 Dec; 336(3):506-10. PubMed ID: 7506676 [TBL] [Abstract][Full Text] [Related]
2. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors. Jensen CJ; Gerard NP; Schwartz TW; Gether U Mol Pharmacol; 1994 Feb; 45(2):294-9. PubMed ID: 7509441 [TBL] [Abstract][Full Text] [Related]
3. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. Rosenkilde MM; Cahir M; Gether U; Hjorth SA; Schwartz TW J Biol Chem; 1994 Nov; 269(45):28160-4. PubMed ID: 7525569 [TBL] [Abstract][Full Text] [Related]
4. Interaction of glutamine 165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists. Fong TM; Yu H; Cascieri MA; Underwood D; Swain CJ; Strader CD J Biol Chem; 1994 May; 269(21):14957-61. PubMed ID: 8195129 [TBL] [Abstract][Full Text] [Related]
5. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor. Huang RR; Yu H; Strader CD; Fong TM Biochemistry; 1994 Mar; 33(10):3007-13. PubMed ID: 7510519 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor. Gether U; Emonds-Alt X; Brelière JC; Fujii T; Hagiwara D; Pradier L; Garret C; Johansen TE; Schwartz TW Mol Pharmacol; 1994 Mar; 45(3):500-8. PubMed ID: 8145735 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor. Cascieri MA; Macleod AM; Underwood D; Shiao LL; Ber E; Sadowski S; Yu H; Merchant KJ; Swain CJ; Strader CD J Biol Chem; 1994 Mar; 269(9):6587-91. PubMed ID: 7509807 [TBL] [Abstract][Full Text] [Related]
8. Variations in affinities for the NK1 receptor: differences between the non-peptide substance P antagonists RP 67580 and CP-96,345 and the agonist septide. Fardin V; Foucault F; Bock MD; Jolly A; Flamand O; Clerc F; Garret C Regul Pept; 1993 Jul; 46(1-2):300-3. PubMed ID: 7692521 [No Abstract] [Full Text] [Related]
9. The role of histidine 265 in antagonist binding to the neurokinin-1 receptor. Fong TM; Yu H; Cascieri MA; Underwood D; Swain CJ; Strader CD J Biol Chem; 1994 Jan; 269(4):2728-32. PubMed ID: 8300604 [TBL] [Abstract][Full Text] [Related]
10. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor. Elling CE; Nielsen SM; Schwartz TW Nature; 1995 Mar; 374(6517):74-7. PubMed ID: 7532789 [TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580. Fong TM; Yu H; Strader CD J Biol Chem; 1992 Dec; 267(36):25668-71. PubMed ID: 1281470 [TBL] [Abstract][Full Text] [Related]
13. Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK-1 receptors. Mantyh CR; Vigna SR; Maggio JE; Mantyh PW; Bollinger RR; Pappas TN Neurosci Lett; 1994 Sep; 178(2):255-9. PubMed ID: 7529913 [TBL] [Abstract][Full Text] [Related]
14. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor. Bremer AA; Leeman SE; Boyd ND FEBS Lett; 2000 Dec; 486(1):43-8. PubMed ID: 11108840 [TBL] [Abstract][Full Text] [Related]
15. Two related neurokinin-1 receptor antagonists have overlapping but different binding sites. Greenfeder S; Cheewatrakoolpong B; Anthes J; Billah M; Egan RW; Brown JE; Murgolo NJ Bioorg Med Chem; 1998 Feb; 6(2):189-94. PubMed ID: 9547942 [TBL] [Abstract][Full Text] [Related]
16. The use of photolabelled peptides to localize the substance-P-binding site in the human neurokinin-1 tachykinin receptor. Girault S; Sagan S; Bolbach G; Lavielle S; Chassaing G Eur J Biochem; 1996 Aug; 240(1):215-22. PubMed ID: 8797856 [TBL] [Abstract][Full Text] [Related]
17. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. Fong TM; Huang RR; Strader CD J Biol Chem; 1992 Dec; 267(36):25664-7. PubMed ID: 1281469 [TBL] [Abstract][Full Text] [Related]
18. Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor. Holst B; Zoffmann S; Elling CE; Hjorth SA; Schwartz TW Mol Pharmacol; 1998 Jan; 53(1):166-75. PubMed ID: 9443945 [TBL] [Abstract][Full Text] [Related]
19. The neurokinin-1 and neurokinin-2 receptor binding sites of MDL103,392 differ. Greenfeder S; Cheewatrakoolpong B; Billah M; Egan RW; Keene E; Murgolo NJ; Anthes JC Bioorg Med Chem; 1999 Dec; 7(12):2867-76. PubMed ID: 10658591 [TBL] [Abstract][Full Text] [Related]
20. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P. Pradier L; Ménager J; Le Guern J; Bock MD; Heuillet E; Fardin V; Garret C; Doble A; Mayaux JF Mol Pharmacol; 1994 Feb; 45(2):287-93. PubMed ID: 7509440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]